The Treatment of Myeloid Malignancies with Kinase Inhibitors, An Issue of Hematology/Oncology Clinics of North America, E-Book

Nonfiction, Health & Well Being, Medical, Specialties, Internal Medicine, Hematology, Oncology
Cover of the book The Treatment of Myeloid Malignancies with Kinase Inhibitors, An Issue of Hematology/Oncology Clinics of North America, E-Book by Ann Mullally, MD, Elsevier Health Sciences
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: Ann Mullally, MD ISBN: 9780323532365
Publisher: Elsevier Health Sciences Publication: July 14, 2017
Imprint: Elsevier Language: English
Author: Ann Mullally, MD
ISBN: 9780323532365
Publisher: Elsevier Health Sciences
Publication: July 14, 2017
Imprint: Elsevier
Language: English

This issue of Hematology/Oncology Clinics will focus on The Treatment of Myeloid Malignancies with Kinase Inhibitors. Articles will focus on: Targeting aberrant signaling in myeloid malignancies: promise versus reality; The development and use of imatinib for the treatment of chronic myelogenous leukemia; Mechanisms of resistance to ABL kinase inhibition in CML and the development of next generation ABL kinase inhibitors; Tyrosine kinase inhibitors in the treatment of systemic mastocytosis and hypereosinophilic syndrome; The development and use of JAK2 inhibitors for the treatment of myeloproliferative neoplasms (MPN); Mechanisms of resistance to JAK2 inhibitors in MPN; Kinase inhibitor screening in myeloid malignancies; and more!

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

This issue of Hematology/Oncology Clinics will focus on The Treatment of Myeloid Malignancies with Kinase Inhibitors. Articles will focus on: Targeting aberrant signaling in myeloid malignancies: promise versus reality; The development and use of imatinib for the treatment of chronic myelogenous leukemia; Mechanisms of resistance to ABL kinase inhibition in CML and the development of next generation ABL kinase inhibitors; Tyrosine kinase inhibitors in the treatment of systemic mastocytosis and hypereosinophilic syndrome; The development and use of JAK2 inhibitors for the treatment of myeloproliferative neoplasms (MPN); Mechanisms of resistance to JAK2 inhibitors in MPN; Kinase inhibitor screening in myeloid malignancies; and more!

More books from Elsevier Health Sciences

Cover of the book Theory and Practice of Physical Pharmacy - E-Book by Ann Mullally, MD
Cover of the book Advances in Pediatrics, E-Book 2015 by Ann Mullally, MD
Cover of the book Stage B, A Pre-cursor to Heart Failure, Part II, An Issue of Heart Failure Clinics - E-Book by Ann Mullally, MD
Cover of the book Emergency Neuroradiology, An Issue of Radiologic Clinics of North America - E-Book by Ann Mullally, MD
Cover of the book Breast Cancer Imaging E-Book by Ann Mullally, MD
Cover of the book Nails by Ann Mullally, MD
Cover of the book Soft Tissue Augmentation E-Book by Ann Mullally, MD
Cover of the book Atlas of Common Pain Syndromes by Ann Mullally, MD
Cover of the book Women's Issues in Gastroenterology, An Issue of Gastroenterology Clinics - E-Book by Ann Mullally, MD
Cover of the book Essentials of Respiratory Care - E-Book by Ann Mullally, MD
Cover of the book Sloane's Medical Word Book - E-Book by Ann Mullally, MD
Cover of the book Robbins and Cotran Pathologic Basis of Disease, Professional Edition E-Book by Ann Mullally, MD
Cover of the book The Student Nurse Handbook by Ann Mullally, MD
Cover of the book Urology for the Pediatrician, An Issue of Pediatric Clinics - E-Book by Ann Mullally, MD
Cover of the book Gene Therapy, An Issue of Hematology/Oncology Clinics of North America, E-Book by Ann Mullally, MD
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy